{"@context":{"@vocab":"https://schema.org/"},"@type":"Legislation","@id":"https://api.ai-analytics.org/trade-case/8329#inv","name":"COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities; Inv. No. 332-596","legislationIdentifier":"332-596","datePublished":"2023-01-21","description":"USITC Factfinding investigation 332-596 — COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities. Concluded 2023-10-17.","url":"https://ids.usitc.gov/case/8101/investigation/8329","isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","investigation":{"investigation_id":8329,"investigation_number":"332-596","case_class":"FACTFINDING","type":"Factfinding (Industry and Economic Analysis)","title":"COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities; Inv. No. 332-596","product":"COVID-19 Diagnostics and Therapeutics: Supply, Demand, and TRIPS Agreement Flexibilities","phase":"Final 1","start_date":"2023-01-21","end_date":"2023-10-17","active":false,"ids_url":"https://ids.usitc.gov/case/8101/investigation/8329","url":"https://api.ai-analytics.org/trade-case/8329"},"_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://ids.usitc.gov/","primary_source_dataset":"USITC Investigations Database System (IDS)","generated_at":"2026-06-27T11:20:57.049Z"}}